SERAQUEST ANTI-THYROGLOBULIN— 510(k) K023592
Substantially EquivalentQuest Intl., Inc.
FDA 510(k) clearance K023592 for SERAQUEST ANTI-THYROGLOBULIN, Substantially Equivalent on 2003-01-06. Applicant: Quest Intl., Inc.. Device class: 2.
Clearance details
- Applicant
- Quest Intl., Inc.
- Product code
- Code DDC
- Device class
- Class 2
- Regulation
- 21 CFR 866.5870
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- North Miami, FL, US
Recent devices under product code DDC
view all- K012208 — ACCESS THYROGLOBULIN ANTIBODY AND CALIBRATORS ON THE ACCESS IMMUNOASSAY SYSTEMS, MODELS 33890, 33895
- K000363 — MODIFICATION TO ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM
- K991610 — ZEUS SCIENTIFIC INC., TPO IGG ELISA TEST SYSTEM.
- K991179 — ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM
- K971835 — ANTI-THYROGLOBULIN (TG) MICROPLATE ELISA
More clearances from Quest Intl., Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.